A phase II study of vorinostat (MK-0683) in patients with primary myelofibrosis and post-polycythemia vera myelofibrosis

C. L. Andersen, N. B. Mortensen, T. W. Klausen, H. Vestergaard, O. W. Bjerrum, H. C. Hasselbalch

Research output: Contribution to journalJournal articleResearchpeer-review

Original languageEnglish
JournalHaematologica
Volume99
Issue number1
Pages (from-to)e5-e7
ISSN0390-6078
DOIs
Publication statusPublished - 1. Jan 2014

Keywords

  • Clinical response
  • Monotherapy
  • Post-polycythemia vera
  • Primary myelofibrosis
  • Vorinostat

Cite this